Overview
Lobbying Costs
5,500,000€ - 5,999,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
11.15 Fte (30)
Lobbyists with EP accreditation
13
High-level Commission meetings
113
Lobbying Costs over the years
-
Info
European Federation of Pharmaceutical Industries and Associations (EFPIA)
EU Transparency Register
38526121292-88 First registered on 04 Mar 2009
Goals / Remit
EFPIA represents the biopharmaceutical industry operating in Europe. Through its direct membership of 36 national associations, 38 leading pharmaceutical companies, and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy. Our vision is for a healthier future for Europe. A future based on prevention, innovation, access to new treatments and better outcomes for patients.
EFPIA’s activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high-quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.Main EU files targeted
Any health or pharmaceutical policy stemming from the European institutions, such as - but not exclusive - Industrial Policy, Pharmaceutical Strategy, pharmaceutical, orphan and paediatrics legislation, Horizon Europe Research Programme, HTA policy, IP policy, One Health Approach to tackle AMR, COVID-19 outbreak measures. EFPIA also follows ongoing trade negotiations and legislative files relevant to the innovative pharmaceutical industry (such as Green Deal, Water Framework Directive, Welfare of animals in scientific testing etc).
Main EU legislative proposals or policies targeted (a non-exhaustive list)
A Pharmaceutical Strategy for Europe – over 50 legislative and non-legislative proposals
• Directive 2001/83/EC on the Community code relating to medicinal products for human use
• Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency
• Regulation (EC) No 141/2000 of the European Parliament and of the Council on orphan medicinal products.
• Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use
In addition, we also follow for example:
• Clinical Trial Regulation
• EMA Fees Regulation
• Europe’s Beating Cancer Plan
• European Health Data Space
• HERA Regulation
• SPCs Regulation revisionAddress
Head Office
8 Rue Mil Neuf Cents
Luxembourg L-2157
LUXEMBOURGEU Office
Rue du Trône 108
Brussels 1050
BELGIUMWebsite
-
People
Total lobbyists declared
30
Employment time Lobbyists 75% 3 50% 11 25% 12 10% 4 Lobbyists (Full time equivalent)
11.15
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
13 accreditations were / are live (in bold) for the selected state of 01 Mar 2023
Name Start date End Date Laurent David Louette 26 May 2023 24 May 2024 Thomas Allvin 01 Mar 2024 28 Feb 2025 Martina D'Amore 27 May 2023 24 May 2024 Athina Giannoutsou 05 Oct 2023 04 Oct 2024 Alexandra Tamas 06 Sep 2023 05 Sep 2024 Sophie Millar 05 Oct 2023 04 Oct 2024 Sibilia QUILICI 18 Oct 2023 17 Oct 2024 Nathalie Moll 13 May 2023 10 May 2024 Kristine PEERS 15 Jul 2023 12 Jul 2024 Mr Thomas Allvin 01 Mar 2024 15 Apr 2024 Ms Sibilia QUILICI 18 Oct 2023 15 Apr 2024 Ms Athina GIANNOUTSOU 05 Oct 2023 15 Apr 2024 Ms Sophie Millar 05 Oct 2023 15 Apr 2024 Ms Athina GIANNOUTSOU 20 Sep 2022 20 Sep 2023 Ms Alexandra Tamas 06 Sep 2023 15 Apr 2024 Ms Kristine PEERS 15 Jul 2023 15 Apr 2024 Ms Martina D'AMORE 27 May 2023 15 Apr 2024 Mr Laurent David LOUETTE 26 May 2023 15 Apr 2024 Ms Nathalie Moll 13 May 2023 15 Apr 2024 Roberta SAVLI 04 May 2023 03 May 2024 Ms Katja STANDKE 13 Apr 2023 15 Apr 2024 Mr Thomas Allvin 24 Jan 2023 24 Jan 2024 Ms Athina Giannoutou 20 Sep 2022 11 Sep 2023 Ms Alexandra Tamas 06 Aug 2022 05 Aug 2023 Ms Sophie Millar 16 Jul 2022 15 Jul 2023 Mr Laurent David LOUETTE 25 May 2022 25 May 2023 Ms Martina D'AMORE 31 May 2022 27 May 2023 Ms Sibilia QUILICI 31 May 2022 31 May 2023 Ms Anna VICERE 25 May 2022 25 May 2023 Mr Laurent David M Louette 25 May 2022 10 Jun 2022 Mr Giacomo Borgo 24 May 2022 24 May 2023 Ms Nathalie Moll 24 May 2022 13 May 2023 Roberta SAVLI 22 Apr 2022 22 Apr 2023 Mr PEDRO MANUEL DIAS DE FIGUEIREDO PEREIRA MARQUES 22 Apr 2022 22 Apr 2023 Ms Alexandra Tamas 14 Aug 2021 06 Aug 2022 Ms Sophie Millar 24 Jul 2021 16 Jul 2022 Mr Koen BERDEN 08 Jun 2021 08 Jun 2022 Ms Martina D'AMORE 04 Jun 2021 31 May 2022 Ms Nathalie Moll 04 Jun 2021 24 May 2022 Ms Sibilia QUILICI 11 May 2021 11 May 2022 Ms Anna VICERE 06 May 2021 06 May 2022 Ms Elizabeth Maria KUIPER 05 May 2021 12 Mar 2022 Mr Giacomo Borgo 05 May 2021 30 Apr 2022 Ms Kristine PEERS 05 May 2021 30 Apr 2022 Ms Magdalena CHLEBUS 05 May 2021 30 Apr 2022 Mr Carlos PARRY LAFONT 29 Oct 2020 05 May 2021 Mr Koen BERDEN 15 Feb 2020 01 Mar 2021 Ms Magdalena RODRIGUEZ DE AZERO MACHADO 04 Feb 2020 04 Feb 2021 Ms anna swierczyna 01 Feb 2020 30 Jan 2021 Ms Lenka Christiaens 09 Jan 2020 09 Jan 2021 Ms Kristine PEERS 05 Oct 2019 03 Oct 2020 Ms Tea Jardas 05 Oct 2019 03 Oct 2020 Mr Giacomo Borgo 05 Oct 2019 03 Oct 2020 Ms Sofia MARCHA 24 Aug 2019 01 Sep 2020 Ms Anna JEDRUSIK 22 Aug 2019 31 Jan 2020 Ms Magdalena CHLEBUS 21 Aug 2019 01 Sep 2020 Ms Nathalie Moll 16 Jul 2019 16 Jul 2020 Mr Giacomo Borgo 01 Dec 2018 05 Oct 2019 Ms Lenka Christiaens 06 Nov 2018 06 Nov 2019 Ms Tea Jardas 06 Nov 2018 05 Oct 2019 Ms Sofia MARCHA 12 Sep 2018 24 Aug 2019 Ms Kristine PEERS 12 Sep 2018 12 Sep 2019 Ms Anna JEDRUSIK 12 Sep 2018 22 Aug 2019 Ms Ioana Enache 01 Aug 2018 31 Oct 2018 Ms Magdalena CHLEBUS 18 Jul 2018 18 Jul 2019 Ms Nathalie Moll 08 Jun 2018 08 Jun 2019 Ms Gabriella Seo ALMBERG 27 Oct 2017 20 Oct 2018 Ms Lenka Christiaens 27 Oct 2017 20 Oct 2018 Ms Ioana Enache 31 Aug 2017 01 Aug 2018 Ms Magda Chlebus 20 Jul 2017 06 Jul 2018 Ms Nathalie Moll 05 May 2017 01 May 2018 Ms Gabriella Seo ALMBERG 28 Oct 2016 27 Oct 2017 Ms Raquel Silva Resendes 20 Oct 2016 10 Jun 2017 Ms Ioana Enache 22 Aug 2016 19 Aug 2017 Ms Magda Chlebus 19 Jan 2016 18 Jan 2017 Mr Richard Arne BERGSTRÖM 11 Dec 2015 09 Dec 2016 Mr Brendan Barnes 27 Nov 2015 30 Nov 2016 Ms Elise Celia Melon 25 Nov 2015 19 Nov 2016 Ms Gabriella Seo ALMBERG 17 Oct 2015 15 Oct 2016 Ms Raquel Silva Resendes 17 Oct 2015 14 Oct 2016 Ms Ioana Enache 29 Jul 2015 27 Jul 2016 Ms Gabriella Seo ALMBERG 28 Oct 2014 17 Oct 2015 Ms Magda Chlebus 21 Jan 2015 19 Jan 2016 Mrs Gabriella Seo ALMBERG 28 Oct 2014 27 Jan 2015 Mr Brendan Barnes 24 Oct 2014 22 Oct 2015 Ms Elise Celia Melon 24 Oct 2014 22 Oct 2015 Ms Raquel Silva Resendes 22 Oct 2014 17 Oct 2015 Ms Anna Krózser 06 Sep 2014 30 May 2015 Mr Richard Arne BERGSTRÖM 17 Jun 2014 13 Jun 2015 Mrs Magdalena Chlebus 06 Dec 2013 05 Dec 2014 Mrs Gabriella Seo ALMBERG 30 Oct 2013 28 Oct 2014 Ms Raquel Silva Resendes 30 Oct 2013 22 Oct 2014 Mr Brendan Barnes 05 Sep 2013 04 Sep 2014 Mrs Angela Lorena PIEDRA HERNANDEZ 11 Sep 2013 10 Sep 2014 Mr Richard Arne BERGSTRÖM 04 Jul 2013 17 Jun 2014 Mrs Isabelle CLAMOU 04 Apr 2013 13 Oct 2013 Mrs Isabelle CLAMOU 07 Mar 2012 02 Apr 2013 Mrs Gabriella Seo ALMBERG 31 Jan 2013 27 Oct 2013 Ms Raquel Silva Resendes 23 Nov 2012 27 Oct 2013 Mrs Gabriella Seo ALMBERG 31 Jan 2012 08 Feb 2013 Mrs Angela Lorena PIEDRA HERNANDEZ 31 Jan 2012 08 Feb 2013 Mr Richard Arne BERGSTRÖM 30 Jan 2012 08 Feb 2013 Isabelle CLAMOU 07 Mar 2012 29 Mar 2013 Complementary Information
30 staff members are involved, however as stated above, the calculation shows the full time equivalent for 11 people.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
BIAC
British Chamber of Commerce
DIA
EACD
EAPM
ECPA
EPAA - European Partnership for Alternative Approaches to Animal
EPC
FAIB
FEAM - Federation of European Academies of Medicine
Friends of Europe
Kangaroo Group
Patients Access Partnership
TOPRA
THE EUROPEAN HOUSE – AMBROSETTIMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
5,500,000€ - 5,999,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount acumen public affairs 100,000€ - 199,999€ ecipe 10,000€ - 24,999€ fti consulting 25,000€ - 49,999€ iqvia 0€ - 10,000€ dolon 0€ - 10,000€ Intermediaries for current year
Name dolon acumen public affairs baker mckenzie Closed year Costs
5,500,000€ - 5,999,999€
Other financial info
According to our calculations, the declared above amount as per guidelines, is correct.
-
EU Structures
Groups (European Commission)
eHealth Stakeholder Group#E02769#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2769 #Member #C#Industry#Multistakeholder expert group to support the application of Regulation (EU) 2016/679#E03537#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3537 #Member #C#Industry#Technical Expert Group for the implementation of the Directive on the protection of animals used for scientific purposes#E02551#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2551 #Member #C#Industry#Competent Authorities' Expert Group on the protection of animals used for scientific purposes#E02539#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2539 #Observer #C#Other#Consultation Forum on Access and benefit sharing (ABS)#E03396#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3396 #Member #C#Industry#Medical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #Observer #C#Industry#Zero Pollution Stakeholder Platform#E03790#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3790 #Member #C#Industry
Groups (European Parliament)
Cancer
Communication activities
EFPIA communications activities include:
• Publishing new evidence (etc. reports, leaflets, infographics) on the policies mentioned above on efpia.eu
• Drafting blog post to share opinions
• Organising events (all virtual in 2021) including EFPIA members and external stakeholders
• Disseminating our key messages through media and social mediaOther activities
EFPIA covers regularly the committee debates in the European Parliament and attends public hearings, conferences, roundtables and similar that are important to the industry. EFPIA also meets on a regular basis Members of the European Parliament and assistants to facilitate the dialogue with the policy makers.
EFPIA has also regular interaction with the European Commission services, including DG GROW, DG SANTE, DG RTD, DG TRADE, DG ENV, etc.
In addition, EFPIA is also is
Accredited stakeholder association to ECHA
Observer to the EU Commission NCP on Dir 2010/63/EU (DG ENV)
Observer to the EU Commission chemicals working group (DG ENV)
Member of the EPAA (DG GROW)
Meetings
Meetings
113 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 03 Apr 2023 Location Brussels Subject Review of EU pharmaceutical regulations Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
-
Date 21 Mar 2023 Location Brussels Subject Revision of the pharmaceutical legislation Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 17 Mar 2023 Location Brussels Subject competitiveness, intellectual property protection, FTAs Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
-
Date 16 Mar 2023 Location Brussels (VTC) Subject Boosting competitiveness and productivity in the EU pharmaceutical industry Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Anthony Whelan (Cabinet member)
-
Date 16 Mar 2023 Location Brussels (VTC) Subject Boosting competitiveness and productivity in the pharmaceutical industry -EFPIA's report Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Anthony Whelan (Cabinet member)
-
Date 10 Feb 2023 Location Brussels Subject employment aspects of the upcoming Pharmaceutical legislation Cabinet Cabinet of Commissioner Nicolas Schmit Portfolio Jobs and Social Rights Attending - Antoine Kasel (Cabinet member)
-
Date 10 Feb 2023 Location Brussels Subject Discussion of upcoming pharmaceutical package; value of predictability (IP), EU pharmaceutical product approval process, competitiveness, unmet medical needs. Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
Other Lobbyists -
Date 09 Feb 2023 Location Brussels Subject Pharma package, competitiveness Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
- Caroline Boeshertz (Cabinet member)
-
Date 08 Feb 2023 Location Brussels Subject Presenting the industry’s point of view on the upcoming pharmaceutical package and on the wider competitiveness, global positioning and resilience aspects. Cabinet Cabinet of Commissioner Johannes Hahn Portfolio Budget and Administration Attending - Kyriacos Charalambous (Cabinet member)
-
Date 02 Feb 2023 Location Brussels Subject Overview of EFPIA’s views on revision of EU pharmaceutical legislation; regulation, competitiveness, new drug development, research and innovation activities in Europe. Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
-
Date 01 Feb 2023 Location Brussels Subject Discussion of the upcoming pharmaceutical legislative package Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
-
Date 17 Oct 2022 Location Virtual Subject EFPIA/EC catch-up on HERA Next meeting of the Joint Cooperation Industrial Forum DG Health Emergency Preparedness and Response Authority Attending - Pierre Delsaux (Director-General)
-
Date 10 Oct 2022 Location Brussels (WEBEX) Subject Conc. Commission proposals to revise the entire EU pharmaceutical legislation by the end of the year Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 29 Jun 2022 Location Brussels Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 29 Jun 2022 Location Brussels Subject Exchange of views on the upcoming pharmaceutical legislation Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 11 May 2022 Location on-line meeting Subject Exchange of views on the upcoming pharmaceutical strategy. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 06 May 2022 Location Online Subject European Health Data Space, Data Act, Data Governance Act Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Werner Stengg (Cabinet member)
-
Date 29 Mar 2022 Location online meeting Subject access to medicines online portal Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Despina Spanou (Cabinet member)
-
Date 16 Mar 2022 Location Brussels (virtual via Webex) Subject EU Pharmaceutical Strategy DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
- Elina Melngaile (Cabinet member)
- Kevin Keary (Cabinet member)
Other Lobbyists -
Date 21 Jun 2021 Location Brussels Subject Pharmaceutical strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists - SANOFI
- Medichem, S.A.
- MEDICINES FOR EUROPE
- European Healthcare Distribution Association
- Phamaceutical Group of the European Union
- Leuphana Universität Lüneburg
- The European Association of Hospital Pharmacists
- Fresenius Kabi Deutschland GmbH
- Novo Nordisk A/S
- European Chemical Industry Council
- European Patients' Forum (EPF)
- Bureau Européen des Unions de Consommateurs
- Pfizer Inc.
- Teva Pharmaceuticals Europe BV
-
Date 07 Jun 2021 Location Brussels Subject VTC meeting - Access to Medicines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 17 May 2021 Location Video conferencing Subject EU vaccine policy Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Michael Hager (Cabinet member)
- Caroline Boeshertz (Cabinet member)
- Cristina Rueda Catry (Cabinet member)
-
Date 25 Mar 2021 Location virtual meeting Subject Biopharmaceutical CEO Roundtable Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 05 Mar 2021 Location Brussels Subject VC Meeting discussion on COVID-19 vaccines export authorisation scheme. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 12 Feb 2021 Location Brussels (virtual) Subject Phone call with EFPIA DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 06 Nov 2020 Location Brussels - virtual Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Oct 2020 Location VTC Subject Stronger “European health union” Cabinet Cabinet of Commissioner Olivér Várhelyi Portfolio Neighbourhood and Enlargement Attending - Szabolcs Horvath (Cabinet member)
-
Date 22 Oct 2020 Location Brussels (Webex) Subject Exchange of views on the upcoming pharmaceutical strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
Other Lobbyists -
Date 20 Oct 2020 Location Virtual meeting Subject Pharmaceutical strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 15 Oct 2020 Location Online meeting Subject Conference on the Future of Europe Health and industrial policies Cabinet Cabinet of Vice-President Dubravka Šuica Portfolio Democracy and Demography Attending - Astrid Dentler (Cabinet member)
- Mattia De Grassi (Cabinet member)
-
Date 06 Oct 2020 Location Brussels Subject Pharmaceuticals strategy, Industrial strategy and trade policy issues Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Nele Eichhorn (Cabinet member)
-
Date 23 Sep 2020 Location Brussels (video conference) Subject EU pharmaceutical strategy and the general approach to IP in pharmaceuticals Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 18 Sep 2020 Location Videoconference Subject Pharmaceutical strategy Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 03 Jul 2020 Location Brussels Subject VC meeting : Exchange of views on the forthcoming Pharmaceutical Strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 29 Jun 2020 Location Brussels Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 10 Jun 2020 Location Brussels Subject Webex meeting upon EFPIA’s request to discuss the forthcoming Pharmaceutical Strategy, the evaluation of the EU Orphan Medicinal Products and Paediatrics regulations and the proposed HTA regulation Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 08 Jun 2020 Location Videoconference Subject Exchange of views on the new pharmaceutical strategy for Europe Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Despina Spanou (Cabinet member)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 05 Jun 2020 Location Brussels (virtual meeting) Subject pharmaceutical strategy of the Commission, SWD on the Orphan and Paediatric Regulation DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 29 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists - Vaccines Europe
- European Confederation of Pharmaceutical Entrepreneurs
- Association of the European Self-Care Industry
- European Patients' Forum (EPF)
- MedTech Europe
- European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry
- European Public Health Alliance
- MEDICINES FOR EUROPE
-
Date 19 May 2020 Location Videomeeting Subject To discuss EU Pharmaceutical Strategy and EU Chemical Strategy and cooperation on green agenda. Cabinet Cabinet of Commissioner Virginijus Sinkevičius Portfolio Environment, Oceans and Fisheries Attending - Camilla Bursi (Cabinet member)
- Virginijus Sinkevičius (Commissioner)
-
Date 15 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 05 May 2020 Location Phone call Subject courtesy call and presentation by EFPIA of their concerns due to COVID crisis and the future of pharmaceutical industry DG Internal Market, Industry, Entrepreneurship and SMEs Attending - Kerstin Jorna (Director-General)
-
Date 29 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 24 Apr 2020 Location Brussels Subject Covid-19 DG Research and Innovation Attending - Jean-Eric Paquet (Director-General)
-
Date 23 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 17 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 02 Apr 2020 Location Brussels (phone call) Subject update on Pharma Strategy DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 27 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 13 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 28 Feb 2020 Location Brussels Subject EFPIA requested a meeting to present their ongoing work Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 11 Feb 2020 Location Brussels, Belgium Subject Health In humanitarian aid and in crisis management Cabinet Cabinet of Commissioner Janez Lenarčič Portfolio Crisis Management Attending - Kasia Jurczak (Cabinet member)
-
Date 11 Feb 2020 Location Brussels, Belgium Subject Pharmaceutical strategy Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Olympia Neocleous (Cabinet member)
-
Date 06 Feb 2020 Location Brussels Subject Medical innovation & Reform policies Cabinet Cabinet of Commissioner Elisa Ferreira Portfolio Cohesion and Reforms Attending - Marlene Madsen (Cabinet member)
-
Date 23 Jan 2020 Location Brussels Subject presentation EFPIA's manifesto Cabinet Cabinet of Commissioner Phil Hogan Portfolio Agriculture & Rural Development Attending - Dermot Ryan (Cabinet member)
-
Date 23 Jan 2020 Location Brussels Subject Integrated health solutions, active ageing, sustainability and quality of healthcare systems, long-term visions on healthcare Cabinet Cabinet of Vice-President Dubravka Šuica Portfolio Democracy and Demography Attending - Astrid Dentler (Cabinet member)
-
Date 23 Jan 2020 Location Brussels Subject presentation EFPIA's manifesto Cabinet Cabinet of Commissioner Phil Hogan Attending - Dermot Ryan (Cabinet member)
-
Date 29 Aug 2019 Location Brussels Subject EFPIA position on the EU preliminary list of US products considered for countermeasures Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Ribokas (Cabinet member)
-
Date 29 Aug 2019 Location Brussels Subject Trade in the pharma sector Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Miguel Ceballos Baron (Cabinet member)
-
Date 23 Jul 2019 Location BREY-Brussels Subject Present their latest Manifesto and introduce the pharmaceutical companies position towards new Commission DG Internal Market, Industry, Entrepreneurship and SMEs Attending - Timo Pesonen (Acting Director-General)
-
Date 26 Jun 2019 Location Brussels Subject Access to medicines, shortages, medicines for rare diseases and children Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Alina Timofte (Cabinet member)
- Arunas Vinciunas (Cabinet member)
-
Date 25 Jun 2019 Location Brussels Subject development of a High-level Forum on Healthcare; the Commission "outcomes" agenda; EU HTA Regulation proposal DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 23 Apr 2019 Location BRUSSELS Subject PPPs in health area DG Research and Innovation Attending - Jean-Eric Paquet (Director-General)
-
Date 04 Feb 2019 Location Brussels Subject Supplementary Protection Certificate Manufacturing Waiver in Europe and EFPIA’s priorities in the context of the 2019 institutional changes Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
-
Date 03 Dec 2018 Location Brussels, Belgium Subject courtesy visit DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 07 Sep 2018 Location Brussels Subject Partnesrhips DG Research and Innovation Attending - Jean-Eric Paquet (Director-General)
-
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists - European Plastics Converters Association
- European Confederation of Pharmaceutical Entrepreneurs
- MedTech Europe
- Medtech & Pharma Platform Association
- Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose
- Association of the European Self-Care Industry
- EuropaBio
- MEDICINES FOR EUROPE
- European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry
-
Date 19 Apr 2018 Location Brussels Subject Competitiveness of the European Pharmaceutical industry Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Risto Artjoki (Cabinet member)
-
Date 21 Mar 2018 Location Brussels Subject competitiveness of the life science industry in Europe Cabinet Cabinet of Vice-President Günther Oettinger Portfolio Budget & Human Resources Attending - Michael Hager (Cabinet member)
-
Date 19 Mar 2018 Location Brussels Subject Health in development cooperation Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 15 Mar 2018 Location Brussels Subject Research & Innovation policy Cabinet Cabinet of Commissioner Tibor Navracsics Portfolio Education, Culture, Youth and Sport Attending - Patricia Reilly (Cabinet member)
-
Date 08 Feb 2018 Location Brussels Subject Possible change of EU patent legislation Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
- Nele Eichhorn (Cabinet member)
-
Date 30 Jan 2018 Location Brussels Subject Exchange of views on current topics Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Elżbieta Bieńkowska (Commissioner)
- Fabrice Comptour (Cabinet member)
-
Date 17 Jan 2018 Location Brussels Subject Role of pharmaceutical industry in development cooperation Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
- Irena Andrassy (Cabinet member)
-
Date 12 Jan 2018 Location Brussels Subject Discussion on AMR DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 15 Dec 2017 Location BRUSSELS Subject AMR; Pharma Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 27 Oct 2017 Location BRUSSELS Subject Meeting with the Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU DG Task Force for Relations with the United Kingdom Attending - Michel Barnier (Head of Task Force)
Other Lobbyists -
Date 29 Jun 2017 Location Brussels Subject Turkey - in breach of rules; Canada - some concerns around implementing legislation. Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
- Christian Burgsmueller (Cabinet member)
-
Date 24 Apr 2017 Location Brussels Subject Follow-up to COUNCIL conclusions: Impact of the incentives on innovation, availability and accessibility of medicinal products Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 31 Jan 2017 Location Brussels Subject Non Communicable diseases Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 07 Dec 2016 Location Brussels Subject Meeting with EPFIA'S President, IMI/Innovation Policy Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
- Giulia Del Brenna (Cabinet member)
-
Date 07 Oct 2016 Location Brussels, Belgium Subject GDPR Cabinet Cabinet of Commissioner Věra Jourová Portfolio Justice, Consumers and Gender Equality Attending - Kevin O'Connell (Cabinet member)
-
Date 15 Jun 2016 Location Brussels Subject HTA, AMR, Access to innovative medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 03 Jun 2016 Location Brussels Subject AMR, Situation in Ukraine Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
-
Date 24 Feb 2016 Location Brussels Subject TTIP, CETA, affordable medicines Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cecilia Malmström (Commissioner)
-
Date 24 Feb 2016 Location Brussels Subject Access to Medicines, HTA, AMR Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
-
Date 24 Feb 2016 Location Brussels Subject Big Data, ehealth DG Günther Oettinger Attending - Günther Oettinger (Commissioner)
-
Date 23 Feb 2016 Location Brussels, Belgium Subject Access to health care and pharmaceuticals in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 25 Nov 2015 Location Brussels Subject AMR DG Health and Food Safety Attending - Xavier Prats Monné (Director-General)
-
Date 19 Nov 2015 Location Brussels Subject TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Miguel Ceballos Baron (Cabinet member)
- Maria Asenius (Cabinet member)
Other Lobbyists -
Date 28 May 2015 Location Brussels, Belgium Subject Developments of pharmaceutical industry Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
-
Date 22 Apr 2015 Location Brussels Subject Trade relations with US and China DG Trade Attending - Jean-Luc Demarty (Director-General)
-
Date 25 Feb 2015 Location Brussels Subject Trade negotiations and health Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)
-
Date 10 Feb 2015 Location Brussels Subject Science and innovation Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Antonio Lowndes Marques De Araujo Vicente (Cabinet member)
-
Date 10 Feb 2015 Location Brussels Subject TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
- Miguel Ceballos Baron (Cabinet member)
-
Date 26 Jan 2015 Location Brussels, Belgium Subject Anti-biotic resistance within development policy Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Paolo Berizzi (Cabinet member)
-
Date 23 Jan 2015 Location Brussels, Belgium Subject EFPIA engagement in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 19 Dec 2014 Location Brussels Subject Innovative Medecines Initiative / Ebola crisis Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 18 Dec 2014 Location Brussels Subject European industry’s perspective on the future of EU research and innovation policy Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)